Axelrod M, Ou Z, Brett LK, Zhang L, Lopez ER, Tamayo AT, Gordon V, Ford RJ, Williams ME, Pham LV, Weber MJ, Wang ML. Combinatorial drug screening identifies synergistic co-targeting of Bruton’s tyrosine kinase and the proteasome in mantle cell lymphoma. Leukemia. 2014;28:407-10. doi: 10.1038/leu.2013.249. Epub 8 Oct 2013
Brett LK, Williams ME. Current and emerging therapies in mantle cell lymphoma. Curr Treat Options Oncol. 2013;14:198-211.
Myint ZW, Sen JM, Watts NL, Druzgal TJ, Nathan BR, Ward MD, Boyer JE, Fracasso PM. Reversible posterior leukoencephalopathy syndrome during Regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors. Clin Colorectal Cancer. 2014;13:127-30. doi: 10.1016/j.clcc.2013.12.003. Epub 2013 Dec 27.
Williams ME, Brett LK, Dreyling M, Ott G, Hsi ED. Mantle cell lymphoma. In: Dreyling M, Williams ME, editors. Rare lymphomas. Heidelberg: Springer; 2014. p. 277-302.
Poster Presentations:
Foster LH, Williams PG, Volodin L, Beitinjaneh A, Petroni G, Laughlin MJ, Kindwall-Keller T. Impact of CD34 cell-dose infused in autologous stem cell transplantation of multiple myeloma patients. American Society for Blood and Marrow Transplantation; 2014.
O’Brien LM, Maitland H, Douvas M, Kindwall-Keller T. Standardizing the Outside Hospital Patient Transfer Process using a safety checklist and electronic communications. Carolinas Health Care System Resident and Fellow Quality Improvement (poster reception); May 2014.
Patel A, Baker MG, Myint ZW, Marks J. Multi-organ failure in the setting of a markedly prolonged PTT: a case of Catastrophic Antiphospholipid Syndrome (CAPS). Southern Society of General Internal Medicine Regional Meeting; New Orleans, February 2014.
